USPTO serial 79435452
LAVENDEZ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 31, 2026
- Examiner
- PEISECKI, MARK A
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LAVENDEZ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
PHARMAKO BIOTECHNOLOGIES PTY LIMITED
AU
Other trademarks owned by PHARMAKO BIOTECHNOLOGIES PTY LIMITED
PHARMAKO BIOTECHNOLOGIES PTY LIMITED
AU
Other trademarks owned by PHARMAKO BIOTECHNOLOGIES PTY LIMITED
PHARMAKO BIOTECHNOLOGIES PTY LIMITED
AU
Other trademarks owned by PHARMAKO BIOTECHNOLOGIES PTY LIMITED
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biochemical reagents for medical or veterinary use; biological preparations for medical use namely, mixed biological preparations for the prevention and treatment of nutritional deficiencies; biotechnological preparations for medical use namely, mixed biological preparations for the prevention and treatment of nutritional deficiencies; dietary supplements for humans and animals; dietary supplements for pharmaceutical purposes; dietetic food and substances adapted for medical or veterinary use; nutraceuticals for use as a dietary supplement; pharmaceutical preparations for the treatment of pain and inflammation; pharmaceutical products and preparations, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products, medical and veterinary preparations for the treatment of alopecia, anxiety, stress, depression and insomnia; pharmaceutical substances for the treatment of damaged skin and tissue; pharmaceuticals for the treatment of gastro-intestinal conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PHARMAKO BIOTECHNOLOGIES PTY LIMITED
- Other trademarks owned by PHARMAKO BIOTECHNOLOGIES PTY LIMITED
- Other trademarks owned by PHARMAKO BIOTECHNOLOGIES PTY LIMITED
- Other trademarks in Class 005
- Similar marks named LAVENDEZ
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 30, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 31, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 10, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 4, 2026 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 19, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 9, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 9, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 6, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 23, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |